Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05752045Not ApplicableUnknown

OphtAI Diagnostic Performance Validation for Automated Screening of Eye Diseases

Role: lead

NCT05380310Not ApplicableUnknown

Impact on the Time to Diagnosis of Serious Postoperative Complications by a Controlled Connected Medical Device

Role: collaborator

NCT04068584Not ApplicableUnknown

Evaluation of the Impact of the SMART ANGEL ™ Device on Follow-up at Home Following Major or Intermediate Outpatient Surgery

Role: collaborator

NCT04668807Not ApplicableUnknown

Technical Capabilities of the "SMART ANGEL Intra-hospital" System 's Connected Medical Device (CMD)

Role: collaborator

All 4 trials loaded